Ovarian Cancer Treatment

Boehringer Ingelheim announced the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent *, for its efficacy and safety as first-line treatment in combination with standard chemotherapy compared to placebo in...  

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may...  

All ovarian cancers are not the same, and a new study suggests gene testing of ovarian tumors may soon allow for more personalized and effective ovarian cancer treatment.  

A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility. In a paper published last week in the Journal of Clinical Oncology, Kutluk Oktay, M.D., professor of obstetrics and gynecology and principal investigator on the study, concluded that mutations in the BRCA1 gene, which have been linked with...  

When a young woman hears the words "you have cancer" she probably can't think beyond the fight for survival. But now, some women are taking steps to protect their hormones, and possibly their future fertility from chemo.  

For the first time, professionals are identifying ovarian cancer symptoms and explains what women, and their doctors, should be on the alert for. Your Cancer Today interviews Dr. Barbara Goff, Director of the Gynecologic Cancer Divi...  

HOUSTON, Dec. 17 /PRNewswire-FirstCall/ -- John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the...  

Talcum Powder and Ovarian Cancer LEARN MORE Cancer Prevention Coalition Web site CPC - 1994 Letter to FDA over dangers of Talc Products Harvard University - Study on talcum powder, 2008 American Cancer society National Cancer Institute on Ovarian Cancer IMAGE SOURCE: Female reproductive system graphic/ National Cancer Institute Web site Talc is the world's softest rock used to make a variety of ...  

Do you find yourself searching for facts about ovarian cancer? Well here are a couple quick facts for you. The ovaries belong to the female reproductive system and produce eggs each month during the reproductive years of a woman. You will fin...  

Background: Liposomal doxorubicin (Doxil) is a cytotoxic chemotherapy drug with a favorable hematologic toxicity profile. Its active drug, doxorubicin, has interesting immunomodulatory properties. Here, the effects of Doxil on surviving tumor cell immunophenotype were investigated. Methods: Using ID8 murine ovarian cancer cells, the immunomodulatory effects of Doxil were studied by measuring its impact on ovarian cancer cell expression of MHC...  

A woman who was constantly approached by strangers asking ... other women with ovarian cysts who have been misdiagnosed Mrs Delaney now has to have blood tests every six months to check for cancer, and so far they have come back clear.  

I'm an Ovarian Cancer survivor. I got married in April of 2008. Shortly after getting married, I got pregnant. I was a little taken aback by this, but was so happy and in love I welcomed this new life growing inside me. I did not enjoy being pregnan...  

New Treatment Could Allow Ovarian Cancer Patients to Keep Having ChildrenKEYCIn Health Watch:For many young women, an ovarian cancer diagnosis can make having children impossible.But now new research shows there may be options. ...More choices for women with ovarian cancer, say researchersKENS 5 TVOvarian Cancer Op Doesn't Have To End FertilityWBZall 3 news articles »  

MLive.comCatholic Central's Brittany Berry thankful doctors caught ovarian cancer earlyMLive.comWhile her ovarian cancer scare was a rare ailment for a teenage girl, she sustained a more common injury at the end of her sophomore season: an ACL injury. ...and more »  

Study Links BRCA1 Gene Mutations to Diminished Ovarian ReserveIVF NEWS.Direct!Deleterious mutations in the BRCA genes greatly enhance the risk of developing breast and ovarian cancer. In a novel finding, researchers at the New York ...